Royal Children s Hospital- Melbourne Information Session
|
|
- Neal Roberts
- 5 years ago
- Views:
Transcription
1 Royal Children s Hospital- Melbourne Information Session The Role of the Lead Site: a CRO Perspective Rebecca Nuhiu PPD Australia Pty Ltd, Associate Country Manager, SIA-ANZ
2 THE ROLE OF THE CRO IN NMA CLINICAL TRIALS Client (Pharma Biotceh) Site CRO Delivery new therapies to improve Health care for Australians Start up team Clinical team 2
3 NMA SUBMISSIONS..THE GOOD VS THE BAD THE GOOD Overall POSITIVE experience. Reduction in the duplication of submissions. Establishment of consistency of core study/site documents such as ICFs; Patient Materials (Cards, Diaries); NEAF (Online Forms) Asof 31 AUG 17-WA is now included on NMA submissions. Conditions and additional documents required to include them. THE BAD Inconsistencyamongst local Ethics committees and RGOs Identifying Proactive and Efficient Lead site Timely receipt of ethics queries and consequent resubmission Communication between lead site/cro/participating sites 3
4 PARTNERSHIP WITH THE LEAD SITE- Sponsor expectations + Critically important to the integrity and success of any clinical trial + CRO partner with the Sponsor to identify lead site. + During feasibility and PSV critical intel is collected from the sites + Key Identifiers of a lead site: Communication Productivity and Motivation Organisation Resource HREC Considerations 4
5 PPD ROLES AND RESPONSIBILITIES OF THE LEAD SITE Providing study documents (Protocol, Draft NMA Master ICF, IB, Patient Material etc), HREA/Online Forms (partially completed), VSM, WA Specific Forms. SITE Clear understanding of local Ethics/RGO requirements- is there anything unique?! Inform PPD of special requirements early. Collecting Signature pages from participating sites Customising and reviewing NMA Master ICF. PPD will provide draft version. Collecting study documents from participating sites for ethics submission Reviewing HREA/Online Forms and adding site specific details. Collecting local site signatures. Ethics queries- answer and prepare cover letter Submitting documents to ethics by agreed deadline Communication with participating sites re: HREC submission, updates and approval Sending participating sites SSA Form once ethics submission is completed. Send ALL HREC approved documents to participating sites Communicating with CRO in timely manner ( ): HREC queries, HREC Approval, Site Delays, Resourcing Issues, Staff leave Collate and QC EDs- send to Sponsor for review and approval Inform site when open to recruitment 5
6 CLEAR COMMUNICATION PROCESSES HREC/ RGO LEAD SITE SPONSOR CRO Participating SITE + Delays are inevitable- it s how we communicate, process and work through them as a team that makes the difference! 6
7 SITE SPECIFIC BUDGETS-WHO IS RESPONSIBLE + Budget template used to negotiate budget requirements for each site separately. Each participating site is solely responsible for their own budget negotiations + Lead site is not responsible for any aspect of budget requirements at a participating site. + Each site has Local Institutional requirements around who negotiates the budget, site costs, reviews and sign off process. + Budgets are always rate limiting step in start up-so please start them early! 7
8 CASE STUDY- WHEN LEAD SITE WORKS WELL + Lead Site has Capacity and Resource + Motivated and Organised Lead Site + Dedicated staff for Ethics/RGO + Documents are provided to the lead site early by CRO + Documents are secured early from lead site AND participating sites (ie CVS, GCP, Radiation Safety Reports) + Clear Communication Pathway + Budget Negotiations in Parallel to HREC + Q-A in 3 months for a public site SITE ETHICS CRO 8
9 CASE STUDY-WHEN LEAD SITE HAS NOT WORKED WELL ETHICS Site CRO + Lack of communication from lead site- no confirmation of receiving submission documents, submission plan, study submission. + Delays from site in receiving communication/queries from HREC (+30days). + Delays with re-submitting queries + ED collection- delays with site obtaining signatures. + Delays patients at the participating sites access to new drug therapy. 9
10 Lead Site: POTENTIAL IMPROVEMENTS + Improved Communication between lead site/cro/participating sites + CRO Inclusion on all communication to HREC and RGO + Dedicated Ethics/governance liaison to support the studies CRO/Sponsor + Improved Communication between lead site/cro/participating sites + Better outline of study requirements and activation timelines provided to lead site. (ie- SIV in late Nov and open for recruitment before Christmas). + Clear understanding of all requirements for opening their site to recruitment and requirements for them as lead. (ie trainings, QC of all study documents-ppd RCR). 10
11 THOUGHTS FOR THE FUTURE + Work towards selling Australia as an attractive and competitive global first choice for Clinical Trials + Improve sustainability to bring new business to the region as we become faster, more reliable and more competitive. + Greater access to wider range of new treatment therapies for Australian patients. + Increase patient enrolment numbers through shorter start up timelines; more patients access to new, innovate and life changing treatments. 11
12 12 QUESTIONS
13 13 Copyright, 2016 by Pharmaceutical Product Development, LLC ("PPD"). All rights reserved. This presentation, including the information contained herein and commentary associated herewith ("materials"), is provided as a service of PPD. These Materials, based on publicly available information as well as the knowledge and experience of PPD's employees, have been prepared solely for informational and educational purposes and should not be relied upon for professional advice. Any further use of these Materials requires the express written consent of PPD.
The Alfred Streamlining Ethical Review Guide. Overview Page 1. The Review Schemes - A description the two different schemes Page 2
The Alfred Streamlining Ethical Review Guide This Guide contains: Overview Page 1 The Review Schemes - A description the two different schemes Page 2 What is meant by Reviewing or Accepting? Page 2 Where
More informationResearch Governance in a public health service. Dr Angela Watt Director Research Governance and Ethics AHRDMA Annual Scientific Meeting 16 June 2017
Research Governance in a public health service Dr Angela Watt Director Research Governance and Ethics AHRDMA Annual Scientific Meeting 16 June 2017 Research Governance Research Governance What & Why? A
More informationStandard Operating Procedures
Standard Operating Procedures 5.7 Site Initiation Version V1.0 Author/s Approved B Fazekas, S Kochovska D Currow Effective date 30/09/2017 Review date 30/09/2019 DO NOT USE THIS SOP IN PRINTED FORM WITHOUT
More informationClinical Trials Assistant POSITION DESCRIPTION
Research Group: Status: Hours: Salary: Reports to: Clinical Trials Assistant POSITION DESCRIPTION Haematology Clinical Trials Part-Time for one (1) year. Role is renewable based on performance and funding
More informationHow/Where Can we Convey the Notion that Clinical Trials are Relevant for Everyone and Thereby Enhance Delivery of Patient Care?
How/Where Can we Convey the Notion that Clinical Trials are Relevant for Everyone and Thereby Enhance Delivery of Patient Care? Dr. Mei Krishnasamy Executive Director of Cancer Nursing and Allied Health
More informationPosition description. Background. Department. Nature of environment. Travel requirements. Key job requirements, responsibilities and duties
Position title: Clinical Research Coordinator Employer: Baker Heart and Diabetes Institute Department: Clinical Diabetes and Epidemiology Supervisor/Manager: Dr Anne Reutens Date: 27 Nov 2017 Background
More informationSTANDARD OPERATING PROCEDURE
STANDARD OPERATING PROCEDURE Title Reference Number Sponsorship SOP-RES-001 Version Number 3 Issue Date 29 th Sep 2016 Effective Date 10 th Nov 2016 Review Date 10 th Nov 2018 Author(s) Reviewer(s) Teresa
More informationNEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES
NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES SOP details SOP title: Site Selection and Initiation SOP number: TM 005 SOP category: Trial Management Version number: 03 Version date: 19 December
More informationManaging multi-site clinical trials
Managing multi-site clinical trials Belinda Fazekas, Linda Devilee Prepared for: CPC Research Colloquium 2015 Flinders University receives funding for PaCCSC from the Australian Government Department of
More informationNEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES
NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES SOP details SOP title: Site Selection and Initiation SOP number: TM-005 SOP category: Trial Management Version number: 04 Version date: 10 July
More informationNational Advance Care Planning Prevalence Study Application Guidelines
National Advance Care Planning Prevalence Study Application Guidelines July 2017 Decision Assist: an Australian Government initiative. Austin Health is the lead site for Decision Assist. TABLE OF CONTENTS
More informationClinical Trial Timeliness- venimus vidimus sed vincimus? Gordon McGurk Director, Clinical Trials Section May 2017
Clinical Trial Timeliness- venimus vidimus sed vincimus? Gordon McGurk Director, Clinical Trials Section May 2017 NHMRC s Government funded initiatives Leading and supporting- Quicker & more efficient
More informationBusiness Process Human Research Ethics Application and Review System
Business Process Human Research Ethics Application and Review System Research and Innovation Services For further information or to update this document contact: Compliance Officer, Research and Innovation
More informationIMPROVING YOUR CLINICAL TRIAL & ENHANCING THE PATIENT EXPERIENCE
ebook IMPROVING YOUR CLINICAL TRIAL & ENHANCING THE PATIENT EXPERIENCE Applying a patient-centered approach to enhance clinical trial performance, improve data quality, and ensure safety and efficacy.
More informationForced Adoption Support Service (FASS) Small Grants Fund
Support Service (FASS) Small Grants Fund Funding Guidelines 2017/2018 Deadline: Monday 8th November 2018 Please read the following guidelines carefully and note the important information. Timeframe to
More informationGuidance for the Tripartite model Clinical Investigation Agreement for Medical Technology Industry sponsored research in NHS Hospitals managed by
Guidance for the Tripartite model Clinical Investigation Agreement for Medical Technology Industry sponsored research in NHS Hospitals managed by Contract Research Organisations (CRO mcia, 2011 version)
More informationNIHR Research for Patient Benefit (RfPB) Application Process
Research Department, Sheffield STANDARD OPERATING PROCEDURE NIHR Research for Patient Benefit (RfPB) Application Process SOP History None SOP Number SOPC114 Created Clinical Research Office Sheffield SUPERSEDED
More informationHuman Research Governance Review Policy
Policy Document Title: Document ID: Document Name: Human Research Governance Review Policy PY-RSH-300304 Human Research Governance Review Policy Version Number: 2 Revision Date: Key Words 28/10/2014 10:40:00
More informationHealth Research Cluster Tactical Research Project Applications Guidelines for Applicants
Key Dates Health Research Cluster Tactical Research Project Applications Guidelines for Applicants Call Open: 14 August 2017 Call Closes: 11.59PM Sunday 10 September 2017 Successful applicant announcement:
More informationNIHR Research for Patient Benefit (RfPB) Application Process
Research Department, Sheffield STANDARD OPERATING PROCEDURE NIHR Research for Patient Benefit (RfPB) Application Process SOP Number C114 Version Number 8.0 Date effective 20/12/2014 Author Daniel Lawrence
More informationThe Northern Ireland Clinical Research Network. Guidance Document
The Northern Ireland Clinical Research Network Guidance Document Document Page NICRN Steering Committee Terms of Reference 2 NICRN Clinical Management Group Terms of Reference 4 NICRN Clinical Lead Role
More informationPresented by NC TraCS Institute UNC Office of Clinical Trials UNC Network of Clinical Research Professionals
ORIENTATION FOR NEW CLINICAL RESEARCH COORDINATORS Presented by NC TraCS Institute UNC Office of Clinical Trials UNC Network of Clinical Research Professionals Overall Agenda for Orientation Module 1:
More informationPhysician / Investigator. Over 40% of clinical trial data are entered into health record and EDC 1
EHR4CR AN INNOVATIVE PLATFORM AND BUSINESS MODEL ACDM Annual Conference, 9 Richard Perkins, eclinical Forum Electronic Health Records for Clinical Research 1 Industry-centric growth in ICT 57% of R&D investment
More informationKeele Clinical Trials Unit
Keele Clinical Trials Unit Standard Operating Procedure (SOP) Summary Box Title SOP Index Number SOP 21 Version 4.0 Approval Date Effective Date Non-Compliance: Deviations and Serious Breaches of GCP and/or
More informationACTIONS/PSOP/001 Version 1.0 Page 2 of 6
1. The purpose of the Pharmacy Site File To enable the designated trust pharmacy to fulfil its role and exercise appropriate control over all aspects of study medication handling, an accurately maintained
More informationStandard Operating Procedure INVESTIGATOR OVERSIGHT OF RESEARCH. Chief and Principal Investigators of research sponsored and/or hosted by UHBristol
Standard Operating Procedure INVESTIGATOR OVERSIGHT OF RESEARCH SETTING FOR STAFF ISSUE Trustwide Chief and Principal Investigators of research sponsored and/or hosted by UHBristol Oversight of research
More informationRESEARCH SERVICE PROVIDER CLINICAL SUPPORT SERVICES HEALTH OUTCOMES SOLUTIONS
RESEARCH SERVICE PROVIDER CLINICAL SUPPORT SERVICES HEALTH OUTCOMES SOLUTIONS Reliability Efficiency Consistency BRACANE COMPANY, INC. IS A CONSULTANCY RESEARCH FIRM LOCATED IN HISTORIC DOWNTOWN PLANO,
More informationPHYSIOTHERAPY PRESCRIBING BETTER HEALTH FOR AUSTRALIA
PHYSIOTHERAPY PRESCRIBING BETTER HEALTH FOR AUSTRALIA physiotherapy.asn.au 1 Physiotherapy prescribing - better health for Australia The Australian Physiotherapy Association (APA) is seeking reforms to
More informationThe implementation of the Clinical Trial Regulation (CTR, n 536/2014) in Belgium. and impact on the ethical review process
1 The implementation of the Clinical Trial Regulation (CTR, n 536/2014) in Belgium and impact on the ethical review process 2 1. Clinical Trials on Medicinal Products for Human Use: Change of the Legal
More information2019 Research Grants Application Guide
1. Introduction This Research Grant serves to outline the overarching funding rules of all Stroke Foundation Research Grants. This document should be read before completing an application form. 2. Background
More informationNovember NHMRC CI Workshop. Dr Cadence Haynes Senior Research Grants Officer, Research Branch
November 2014 NHMRC CI Workshop Dr Cadence Haynes Senior Research Grants Officer, Research Branch Welcome thanks for attending Congratulations to Investigators on new grants and fellowship! Purpose of
More informationAsk the Experts Panel
Ask the Experts Panel Compliance in Research Colleen Fritsche, Assistant Director of Office of Animal Care and Use Cassie Myers, Deputy Director of Office of Human Research Ethics Chris Nelson, Director
More informationADMINISTRATION OF INSULIN IN THE COMMUNITY BY ATTENDANT CARE SUPPORT WORKERS
Title Purpose ADMINISTRATION OF INSULIN IN THE COMMUNITY BY ATTENDANT CARE SUPPORT WORKERS This guideline is to assist: Attendant care service providers (organisations and individuals), participants, stakeholders
More informationSOP16: Standard Operating Procedure for Establishing Sites and Centres - Site Setup
SOP16: Standard Operating Procedure for Establishing Sites and Centres - Site Setup Authorship Team: Leanne Quinn for Joint SOP Group on Trial Processes (viz Ian Russell, Anne Seagrove, Jemma Hughes, Yvette
More informationR. Fay, Research Governance & GCP Manager K. Mahiouz, Clinical Trials Facilitator E. Clough, R&D Governance Operations Manager
Standard Operating Procedures (SOP) for: BH/QMUL Sponsorship of CTIMPs, ATMPs and Clinical Trials of non- CE marked Medicinal Devices Process for Researchers SOP Number: 11a Version Number: V1.0 Effective
More informationPERFORMANCE IN INITIATING AND DELIVERING CLINICAL RESEARCH INFORMATION SUBMISSION GUIDELINES
PERFORMANCE IN INITIATING AND DELIVERING CLINICAL RESEARCH INFORMATION SUBMISSION GUIDELINES Version Control Item 20 Items 22, 23 Item 27 Added item regarding responsibility of providers to submit successfully
More informationMEDICINES FOR HUMAN USE (CLINICAL TRIALS) REGULATIONS Memorandum of understanding between MHRA, COREC and GTAC
MEDICINES FOR HUMAN USE (CLINICAL TRIALS) REGULATIONS 2004 Memorandum of understanding between MHRA, COREC and GTAC 1. Purpose and scope 1.1 Regulation 27A of the Medicines for Human Use (Clinical Trials)
More informationApproved by. The Board of Directors of RusnanoMedInvest, LLC. Minutes # 3 dated April 24, 2012
Approved by The Board of Directors of RusnanoMedInvest, LLC Minutes # 3 dated April 24, 2012 Regulation on R&D expert review process in RusnanoMedInvest, LLC (RMI) Moscow 2012 1. General Regulation 1.1.
More informationTHE FRANK DOWNING SCHOLARSHIP. May 2018
THE FRANK DOWNING SCHOLARSHIP May 2018 Summary The Frank Downing Scholarship has been established to honour Frank Downing CBE QC, who had a long and distinguished career as a leading commercial lawyer
More informationComprehensive Protocol Feasibility Questionnaire
Protocol Title: Potential Principal Investigator: Regulatory Coordinators: Department Chair: PROJECT FEASIBILITY PI and Study Team: YOUR RESPONSES TO THIS SURVEY CONSTITUTE A BEST ESTIMATE OF RESOURCES
More informationOFFICE FOR RESEACH PROCEDURE. Documentation of Investigational Site Qualifications, Adequacy of Resources and Training Records
OFFICE FOR RESEACH PROCEDURE Documentation of Investigational Site Qualifications, Adequacy of Resources and Training Records 1. Purpose: To describe the procedures related to the appropriate documentation
More informationPolicy for Access to MINDACT Biological Materials and Data
Policy for Access to MINDACT Biological Materials and Data Public Version 8 Contents 1. Introduction... 3 2. Glossary... 3 3. Governance and responsibilities... 5 4. General principles... 5 5. Review Procedures...
More informationIngham Institute for Applied Medical Research Clinical Trials Coordinator POSITION DESCRIPTION
Ingham Institute for Applied Medical Research Clinical Trials Coordinator POSITION DESCRIPTION Research Group: Status: Hours: Salary: Reports to: Haematology Clinical Trials Full-time for one (1) year.
More informationRequest for Quotation
Request for Quotation For support and preparation of the Cambridge Future Cities Stage 2 Large Scale Demonstrator feasibility study and final report production www.cambridgeshire.gov.uk TSB Future Cities
More informationGuide For Prospective Authors Submitting Manuscript Proposals
Guide For Prospective Authors Submitting Manuscript Proposals PLD Learning Resources is an Australian company specialising in the publication of resources for 3 to 11 year olds. The company was established
More informationVCU Clinical Research Quality Assurance Assessment
VCU Clinical Research Quality Assurance Assessment Principal Investigator Protocol Title Protocol IRB Number Name of Person Completing Assessment Date Assessment was Completed The goal of this assessment
More informationNSW Regional Health Partners. Targeted Project EOI Application Guide for MRFF 2018
NSW Regional Health Partners Targeted Project EOI Application Guide for MRFF 2018 This form is to be used as a guide to complete the MRFF Expression of Interest for the NSW Regional Health Partners. This
More informationEuropean CRO Federation
European CRO Federation The interface between Industry CRO and Clinical Trials Networks: Defining the Roles EMA, London, 22 March 2012 Dr. Martine Dehlinger-Kremer Vice President Global Regulatory Affairs,
More informationQuality Assurance in Clinical Research at RM/ICR. GCP Compliance Team, Clinical R&D
Quality Assurance in Clinical Research at RM/ICR GCP Compliance Team, Clinical R&D Slide 1 of 13 What is Quality Assurance? The maintenance of a desired level of quality in a service or product, especially
More informationGrünenthal Norway AS - Methodological Note
Grünenthal Norway AS - Methodological Note Guidelines for Implementing the EFPIA Disclosure (Transparency) Code for the Reporting Year 2016 Preamble As a member company of the European Federation of Pharmaceutical
More informationSite Closedown Checklist for UoL Sponsored CTIMP Studies
Site Closedown Checklist for UoL Sponsored CTIMP Studies Site Information Site: Study Title: UoL study number: Centre name: Investigator: Date of Visit: Date of Report Date Responses due by: List of site
More informationCPD Endorsement Process and Application
F: ED01/14 CPD Endorsement Process and Application What is CPD endorsement? 1 Continuing Professional Development CPD endorsement is a quality assurance process whereby CPD activities are assessed and
More informationClinical Trials Where World Class Care Begins
Office of Clinical Trials Clinical Trials Where World Class Care Begins We seek to attract novel, innovative and transformational research and devices to our medical center and its stakeholders, and serve
More informationGuideline for the notification of serious breaches of Regulation (EU) No 536/2014 or the clinical trial protocol
1 2 31 January 2017 EMA/430909/2016 3 4 5 Guideline for the notification of serious breaches of Regulation (EU) No 536/2014 or Draft Adopted by GCP Inspectors Working Group (GCP IWG) 30 January 2017 Adopted
More informationStandard Operating Procedures
Standard Operating Procedures 6.5.1 Study Recruitment 2008 History Versi Date Author Reason on 1.1 18 th July 2007 B Fazekas New procedure 1.2 21 st January B Fazekas Update after MAB review 2008 1.3 19
More informationAn invitation to tender for the contract of marketing campaign developer for the Own Art scheme.
An invitation to tender for the contract of marketing campaign developer for the Own Art scheme. 1. Invitation to Tender 1.1 The purpose of this document is to invite tenders to oversee and develop two
More informationPHARMACY, MEDICINES & POISONS BOARD GUIDELINES FOR REVIEW/EVALUATION CLINICAL TRIAL APPLICATIONS FOR VACCINES AND BIOLOGICALS MALAWI
PHARMACY, MEDICINES & POISONS BOARD GUIDELINES FOR REVIEW/EVALUATION OF CLINICAL TRIAL APPLICATIONS FOR VACCINES AND BIOLOGICALS IN MALAWI 1. INTRODUCTION The clinical trial application must undergo a
More informationCOMMISSIONING SUPPORT PROGRAMME. Standard operating procedure
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE COMMISSIONING SUPPORT PROGRAMME Standard operating procedure April 2018 1. Introduction The Commissioning Support Programme (CSP) at NICE supports the
More informationAN OVERVIEW OF CLINICAL STUDY TASKS AND ACTIVITIES
1 AN OVERVIEW OF CLINICAL STUDY TASKS AND ACTIVITIES Key Clinical Study Tasks and Activities 2 Discussion of Key Tasks and Activities 3 Development of the Clinical Protocol and Study Materials 3 Qualification
More informationmanaging or activities.
STANDARD OPERATING PROCEDURE Clinical Research Monitoring TITLE: Site Initiation Visit TITLE: Site Initiation Visit 1. PURPOSE SOP Number: Version: 1.0 MICHR CRM MON 002 Effective Date: 19Dec2013 1.1 This
More informationDocument Title: Site Selection and Initiation for RFL Sponsored Studies Document Number: 026
Document Title: Site Selection and Initiation for RFL Sponsored Studies Document Number: 026 Version: 1.1 Ratified by: Committee Date ratified: 03/10/2017 Name of originator/author: Directorate: Department:
More informationSARASOTA MEMORIAL HOSPITAL CANCER RESEARCH PROGRAM POLICY
PS1006 SARASOTA MEMORIAL HOSPITAL CANCER RESEARCH PROGRAM POLICY TITLE: Satellite Site Management Plan Job Title of Reviewer: POLICY #: EFFECTIVE DATE: REVISED DATE: POLICY TYPE: Elizabeth Carr, R.N.,
More informationAddendum 1 Compliance indicators for the Australian Privacy Principles
Healthy Profession. Computer and security standards Addendum 1 indicators for the Australian Privacy Principles The compliance indicators for the Australian Privacy Principles (APP) matrix identify the
More informationAustralia-China Young Researchers Exchange Program Application Form 2013
Australia-China Young Researchers Exchange Program Application Form 2013 This Project is supported by the Commonwealth of Australia under the Australia-China Science and Research Fund Application pack
More informationFrequently Asked Questions. The CIRB is located at 168 Jalan Bukit Merah #06-08 Tower 3 Connection One Singapore
1. Where is the location of the CIRB? The CIRB is located at 168 Jalan Bukit Merah #06-08 Tower 3 Connection One Singapore 150168. 2. When is the submission deadline? The CIRB meets once a month. The submission
More informationAustralian Medical Council Limited
Australian Medical Council Limited Procedures for Assessment and Accreditation of Specialist Medical Programs and Professional Development Programs by the Australian Medical Council 2017 Specialist Education
More informationAboriginal and Torres Strait Islander Health Practice Accreditation Committee - list of approved accreditation assessors
Call for applications September 2016 Aboriginal and Torres Strait Islander Health Practice Accreditation Committee - list of approved accreditation assessors Guide for applicants This information package
More informationPosition Title Flagstaff AOD (FAOD) Practitioner Classification & Stream (if
Position Title Flagstaff AOD (FAOD) Practitioner Classification & Stream (if Social, Community, Home Care and Disability Services industry Award 2010 (SCHCADS) Level 5 applicable) Division The Salvation
More informationGilead UK & Ireland Corporate Contributions Grant FAQs
Gilead UK & Ireland Corporate Contributions Grant FAQs Gilead supports many organisations and projects, but we receive more grant requests than we are able to fund. Applying for a grant is not a guarantee
More informationWhy do we need an addendum to ICH E6?
Addendum to ICH E6 Hideaki Ui, Ph.D. Inspection Director Office of Non-clinical and Clinical Compliance Pharmaceuticals and Medical Devices Agency, Japan Disclaimer The views and opinions expressed in
More informationHIGH VALUE DATA COLLECTIONS: PRIORITIES FOR DEVELOPMENT OF LINKED DATA RESOURCES IN AUSTRALIA
HIGH VALUE DATA COLLECTIONS: PRIORITIES FOR DEVELOPMENT OF LINKED DATA RESOURCES IN AUSTRALIA September 2017 Except for the PHRN logo and content supplied by third parties, this copyright work is licensed
More informationUNITAID PROPOSAL PROCESS
UNITAID PROPOSAL PROCESS CONTENTS 1. ABOUT UNITAID... 3 2. GENERAL INFORMATION... 3 3. UNITAID PROPOSAL PROCESS... 4 3.1. PROPOSAL PROCESS... 4 3.2. GRANT AGREEMENT PROCESS... 7 4. GENERAL PRINCIPLES AND
More informationUSING SMART IRB AND SINGLE IRB REVIEW
USING SMART IRB AND SINGLE IRB REVIEW Jeannie Barone Director, HRPO ATTRIBUTES Special thanks to Nichelle Cobb, PhD from University of Wisconsin-Madison for her permission to utilize her slides on SMART
More informationDocument Title: GCP Training for Research Staff. Document Number: SOP 005
Document Title: GCP Training for Research Staff Document Number: SOP 005 Version: 2 Ratified by: Version 2, 04/10/2017 Page 1 of 13 Committee Date ratified: 26/10/2017 Name of originator/author: Directorate:
More informationINDUSTRY MENTORING NETWORK IN STEM
INDUSTRY MENTORING NETWORK IN STEM MENTEE APPLICATION FORM MedTech-Pharma Program (Medical Technologies & Pharmaceuticals) 1. Program I am applying to the following IMNIS program (please select only one):
More informationEMA & FDA Inspections: Site perspective. Shandukani Research Centre
EMA & FDA Inspections: Site perspective Shandukani Research Centre Why were we inspected? Pharmaceutical company applied for registration of the study drug (Phase I/II dosing studies in paediatrics) Large
More informationBUILDING VIRTUAL CARE SCALABILITY INTO REGIONAL HEALTH SERVICES AND TO CONDUCTING CLINICAL TRIALS
BUILDING VIRTUAL CARE SCALABILITY INTO REGIONAL HEALTH SERVICES AND TO CONDUCTING CLINICAL TRIALS Professor Sabe Sabesan Director of Medical Oncology, Townsville Cancer Centre Townsville Hospital and Health
More informationGrants in. Australia. Survey
Grants in Australia Survey About the Survey The 2007 Australian Institute of Grants Management (AIGM) Grants in Australia Survey marks the second year we have asked questions to Australian grantseekers
More informationEffective solutions for your business writing and projects
Effective solutions for your business writing and projects CAPABILITY STATEMENT Tel: 0409 069 425 admin@indigogold.com.au www.indigogold.com.au Indigo Gold is passionate about helping organisations to
More informationStandard Operating Procedure (SOP) for Reporting Serious Breaches in Clinical Research
Standard Operating Procedure (SOP) for Reporting Serious Breaches in Clinical Research For Completion by SOP Author Reference Number PHT/RDSOP/002 Version V2.0 07 Apr 2016 Document Author(s) Document Reviewer(s)
More informationThe changing regulatory and governance environment. for health research across the UK. a guide for researchers. November 2009 v.1
The changing regulatory and governance environment for health research across the UK a guide for researchers November 2009 v.1 UK Clinical Research Collaboration 20 Park Crescent London W1B 1AL United
More informationIntroduction to the United States Food and Drug Administration (FDA) and FDA Inspection Process VOICE
Introduction to the United States Food and Drug Administration (FDA) and FDA Inspection Process VOICE 2011 MTN Annual Meeting March 27, 2011 Lisa Noguchi, MSN Donna Germuga, DAIDS, OCSO, RN, BSN Objectives
More informationSOP: New Revised Reviewed Effective Date: 08 October Approved by : Supervisor/Manager Risk/Ethics Sr. Mgmt Committees Board/Councils
Title: Assessment of Study Feasibility Manual: RI MUHC Policies and Procedures Human Research SOPs Originating Dept/ Service: RI MUHC Division of Clinical Research SOP: New Revised Reviewed Effective Date:
More informationRESEARCH FELLOWSHIPS GUIDE TO APPLICANTS/CONDITIONS OF AWARD Funding to commence in 2019
RESEARCH FELLOWSHIPS GUIDE TO APPLICANTS/CONDITIONS OF AWARD Funding to commence in 2019 Closing Date for full applications: 4pm, Friday 25 th May 2018 Introduction and purpose The Cancer Council Western
More informationCOMPETENCY FRAMEWORK
COMPETENCY FRAMEWORK Theresa Ledger Lead Nurse Research and Development Clinical Research Facility Sheffield C:\Documents and Settings\Robertus\My Documents\Mariann\CRF\CRF Portfolio and Competency Template_DRAFT
More informationStandard Operating Procedure
Standard Operating Procedure SOP number: SOP full title: SOP-JRO-07-004 Recording, managing and reporting Adverse Events for Clinical Trials of Investigational Medicinal Products and trials of Advanced
More informationOnce the feasibility assessment has been conducted the study team will be notified via (Appendix 3) of the outcome and whether the study is;
1. INTRODUCTION 2. SCOPE Feasibility assessments will ascertain any operational concerns about a research study which may delay NHS Permission or cause issues with study delivery. By conducting an assessment
More informationThe GCP Perspective on Study Monitoring
The GCP Perspective on Study Monitoring Heidi Judge, CCRP Sr. Clinical Trials Project Manager Clinical Trials Network and Institute Massachusetts General Hospital 1 Overview Monitoring Basics Who, What,
More informationClinical Research Nurse Position Description
Date: September 2015 Job Title : Clinical Research Nurse Department : Haematology Research Unit General Medicine & Older People Location : North Shore Hospital Reporting To : Operationally to: Operations
More information2017/2018 Prostate Cancer Innovation Fund Terms of Reference
2017/2018 Prostate Cancer Innovation Fund Terms of Reference I. Table of Contents II. Background... 2 III. Key Dates... 2 IV. Objectives and Scope... 2 V. Eligibility... 3 A. Eligible Applicants... 3 B.
More informationClinical Trial Readiness Checklist October 2014
The clinical trial readiness checklist is a tool which can help new and experienced researchers prepare for upcoming clinical studies. It is designed to be a quick reference to ensure that you have the
More informationAuditing of Clinical Trials
Version 1.2 Effective date: 3 September 2012 Author: Approved by: Claire Daffern, QA Manager Dr Sarah Duggan, CTU Manager Revision Chronology: Effective Date Version 1.2 3 Sept 2012 Version 1.1 12 May
More informationRegulatory Inspections
Regulatory Inspections An Overview of Process, Observations, and Guidance for Investigators Alison Urton, Group Administrator Clive Hansen, Audit Team Leader Outline Regulatory History Health Canada Overview
More informationNational Research Ethics Service
National Research Ethics Service NRES Committee North West - Haydock HRA NRES Centre - Manchester 3rd Floor - Barlow House 4 Minshull Street Manchester M1 3DZ 16 May 2014 Telephone: 0161 625 7827 Facsimile:
More informationRMI Researched Medicines Industry Association
RMI Researched Medicines Industry Association Submission to: Medsafe On the: Proposed Clinical Trials Guidelines 30 November 2009 Contact Kevin Sheehy, Scientific and Technical Manager RMI, Level 8, 86
More informationNavigating the Clinical Research Landscape in the NHS. How the Clinical Research Network can help you Generate the Evidence
Navigating the Clinical Research Landscape in the NHS How the Clinical Research Network can help you Generate the Evidence Lydia Christopher Head of Industry Operations, NIHR Clinical Research Network
More informationACRRM Telehealth Advisory Committee Standards Framework
www.ehealth.acrrm.org.au ACRRM Telehealth Advisory Committee Standards Framework ATHAC 1 Telehealth Standards Framework Purpose The purpose of the ATHAC Telehealth Standards Framework is to provide health
More informationJoint R&D Support Office SOP S-2011 UHL
UNIVERSITY OF LEICESTER & UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST JOINT RESEARCH & DEVELOPMENT SUPPORT OFFICE STANDARD OPERATING PROCEDURES Joint R&D Support Office SOP S-2011 UHL Site Initiation for
More informationGuidance for the Applicants: Gilead Sciences Nordic Fellowship Programme 2017
Guidance for the Applicants: Gilead Sciences Nordic Fellowship Programme 2017 This is the fifth year of the Gilead Sciences Nordic Fellowship Programme. Applications are invited from health-care organisations
More informationJanssen Policy Evaluating and Responding to Pre-approval Access Requests for Investigational Medicines
Janssen Policy Evaluating and Responding to Pre-approval Access Requests for Investigational Medicines PURPOSE This policy establishes the principles by which the Janssen Pharmaceutical Companies of Johnson
More information